2345.TW (2345.TW)

$913.8B
Market Cap
34.9
P/E Ratio
0.18
Beta
0.66%
Dividend Yield
Piotroski 7/9Altman Z 9.6 SafeROIC−WACC +34.7%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 7/9, Altman Z 9.6 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency is exceptionally robust, evidenced by a return on invested capital of 42.7% that significantly outpaces the weighted average cost of capital at an 8.0% hurdle rate, generating a wide +34.7% spread indicative of durable competitive advantages and high-quality earnings generation. This profitability profile is underpinned by strong operational leverage, where net margins of 10.6% operate within healthy gross margin parameters of 18.1%, while the revenue base expands at an accelerated pace of 124.9% year-over-year. Financial stability metrics further corroborate this fundamental strength; a Piotroski F-Score of 7/9 suggests high financial resilience and improving balance sheet conditions, complemented by an Altman Z-Score of 9.6 that places the entity well within the safe zone for bankruptcy avoidance.

Valuation multiples reflect significant market optimism regarding future earnings sustainability rather than current cash flows alone, as the trading price implies a forward P/E ratio of approximately 34.9x. This premium multiple stands in contrast to implied growth expectations derived from discounting models that assign a fair value of $2745; however, without explicit historical sector benchmarks or specific market-implied growth rates provided for comparison, it remains unclear whether current pricing fully incorporates the trajectory required to justify such an expansion over time. The divergence between the high multiple and the DCF-derived target suggests the market is pricing in aggressive long-term execution rather than relying solely on the already realized revenue explosion.

While the data points toward a compelling risk-reward asymmetry driven by superior capital returns, no specific Fama-French alpha adjustments or insider trading activity patterns are available to refine the probability distribution of future outcomes. Consequently, while the fundamental economics display signs of a high-quality compounder with minimal distress risk, the elevated valuation multiples introduce sensitivity to any deviation from the projected growth path that current pricing assumes will persist indefinitely.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6%8%10%
2%$3588$2347$1730
3%$4658$2745$1928
4%$6800$3341$2192

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=8.0%, terminal growth 3%. Fair value $2745 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
9.6
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

18.1%
Gross Margin
10.6%
Net Margin
42.7%
ROIC
8.0%
WACC
ROIC − WACC Spread: +34.7%— Positive value creation spread.
+124.9%
Revenue Growth (YoY)
+119.5%
Earnings Growth (YoY)
29.8B
Free Cash Flow
21%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

1.49x
Debt / Equity
1.47x
Current Ratio
330.2x
Interest Coverage
-0.8x
Net Debt / EBITDA
3.37%
FCF Yield
34.7B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $7.13
Act: $9.17
+28.7%
Q3
✓ Beat
Est: $8.80
Act: $8.96
+1.8%
Q2
✓ Beat
Est: $13.57
Act: $13.94
+2.7%
Q1
✓ Beat
Est: $13.34
Act: $14.81
+11.0%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

19.6
Forward P/E
PEG Ratio
15.88
Price/Book
5M
Avg Volume
$1750.00
52W High
$430.50
52W Low
52W Range Position

ETF Contagion Visualizer

Simulate a price drop in 2345.TW to visualize passive redemption contagion across ETFs and collateral stocks.

2345.TW Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
2345.TWEpicenterEWTETF2330.TWLow Risk2308.TWLow Risk2454.TWLow Risk2317.TWMed Risk2383.TWLow Risk
2345.TW Price Drop (%)0

If 2345.TW (2345.TW) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Taiwan Semiconductor Manufacturing Co Ltd (2330.TW) as the most exposed collateral stock, sharing 1 ETFs with 2345.TW. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 1 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

2345.TW Ownership Dynamics

Ticker
2345.TW

ETFs with Highest 2345.TW Exposure

Float lock-up computed from 0 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

2345.TW Capital Efficiency

How efficiently does 2345.TW convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$29.8B
EBITDA
$34.7B
FCF Conversion
86%
Reinvestment Rate
14%
86% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
42.7%
ROIC − WACC Spread
34.7%

2345.TW converts 86% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 34.7% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare 2345.TW to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.